SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Pharmaceutical Prices under Regulation: Tiered Co-payments and Reference Pricing in Germany
16 references·16 citing·47 second hopsampled
Pharmaceutical Prices under Regulation: Tiered Co-payments and Reference Pricing in Germany (2012)Pharmaceutical Prices under Regulation: T…The impact of the termination rule on cooperation in a prisoner’s dilemma experiment (2012)The impact of the termination…Competition Policy and Productivity Growth: An Empirical Assessment (2012)Competition Policy and Produc…How effective is European merger control? (2011)How effective is European mer…Patient Cost-Sharing and Hospitalization Offsets in the Elderly (2010)Patient Cost-Sharing and Hosp…A within-subject analysis of other-regarding preferences (2010)A within-subject analysis of …Pharmaceutical Price Controls and Entry Strategies (2007)Pharmaceutical Price Controls…Uncertainty and Learning in Pharmaceutical Demand (2005)Uncertainty and Learning in P…Generic Drug Industry Dynamics (2005)Generic Drug Industry DynamicsParallel imports and the pricing of pharmaceutical products: evidence from the European Union (2004)Parallel imports and the pric…Testing for Serial Correlation in Linear Panel-data Models (2003)Testing for Serial Correlatio…Econometric Analysis of Cross Section and Panel Data (2001)Econometric Analysis of Cross…Review of the literature on reference pricing (2000)Review of the literature on r…The Importance of the Physician in the Generic versus Trade-Name Prescription Decision (1998)The Importance of the Physici…Generic Entry and the Pricing of Pharmaceuticals (1997)Generic Entry and the Pricing…Brand Loyalty, Entry, and Price Competition in Pharmaceuticals after the 1984 Drug Act (1992)Brand Loyalty, Entry, and Pri…Health insurance and the demand for medical care: evidence from a randomized experiment. (1987)Health insurance and the dema…Consumer flexibility, data quality and location choice (2016)Consumer flexibility, data qu…Policy-Induced Environmental Technology and Inventive Efforts: Is There a Crowding Out? (2015)Policy-Induced Environmental …Optimal Damages Multipliers in Oligopolistic Markets (2015)Optimal Damages Multipliers i…Mergers, Managerial Incentives, and Efficiencies (2014)Mergers, Managerial Incentive…Endogenous cartel formation: Experimental evidence (2014)Endogenous cartel formation: …Downstream mode of competition with upstream market power (2014)Downstream mode of competitio…Do Leniency Policies facilitate Collusion? Experimental Evidence (2014)Do Leniency Policies facilita…Do buyer groups facilitate collusion? (2014)Do buyer groups facilitate co…Why are educated and risk-loving persons more mobile across regions? (2013)Why are educated and risk-lov…Rebels without a Clue? Experimental Evidence on Partial Cartels (2013)Rebels without a Clue? Experi…Input Price Discrimination (Bans), Entry and Welfare (2013)Input Price Discrimination (B…Independent Service Operators in ATM Markets (2013)Independent Service Operators…Excess Capacity and Pricing in Bertrand-Edgeworth Markets: Experimental Evidence (2013)Excess Capacity and Pricing i…Effects of different cartel policies: evidence from the German power-cable industry (2013)Effects of different cartel p…An equilibrium analysis of efficiency gains from mergers (2012)An equilibrium analysis of ef…Demand Estimation with Selection Bias: A Dynamic Game Approach with an Application to the US Railroad Industry (2011)Demand Estimation with Select…Large shareholders and firm performance—An empirical examination of founding-family ownership (2008)Panel Data Econometrics in R : The plm Package (2008)Bank Risk-taking, Securitization, Supervision, and Low Interest Rates: Evidence from the Euro-area and the U.S. Lending Standards (2011)Econometric Analysis of Panel Data (2021)Free for All? Lessons from the RAND Health Insurance Experiment (1995)Who Ordered That? The Economics of Treatment Choices in Medical Care (2011)A review of the differences and similarities between generic drugs and their originator counterparts, including economic benefits associated with usage of generic medicines, using Ireland as a case study (2013)Behavioral Hazard in Health Insurance * (2015)The Quarterly Journal of Economics (2024)Industrial Market Structure and Economic Performance. (1971)Product differentiation advantages of pioneering brands (1980)Killer Acquisitions (2020)Equilibrium in Competitive Insurance Markets: An Essay on the Economics of Imperfect Information (1976)Limited-dependent and qualitative variables in econometrics (1983)Medical Care Costs: How Much Welfare Loss? (1992)UNCERTAINTY AND THE WELFARE ECONOMICS OF MEDICAL CARE (2003)The Oregon Health Insurance Experiment: Evidence from the First Year* (2012)Best care at lower cost: the path to continuously learning health care in America (2014)Patent Expiration, Entry, and Competition in the U.S. Pharmaceutical Industry (1991)Estimating the Effects of Global Patent Protection in Pharmaceuticals: A Case Study of Quinolones in India (2006)Autoregressive Conditional Heteroscedasticity with Estimates of the Variance of United Kingdom Inflation (1982)Some Tests of Specification for Panel Data: Monte Carlo Evidence and an Application to Employment Equations (1991)Another look at the instrumental variable estimation of error-components models (1995)Estimating Standard Errors in Finance Panel Data Sets: Comparing Approaches (2008)Corporate social responsibility and access to finance (2013)The China Syndrome: Local Labor Market Effects of Import Competition in the United States (2013)Information and Consumer Behavior (1970)Job Matching and the Theory of Turnover (1979)The Effect of Expected Income on Individual Migration Decisions (2003)Chapter 63 Econometric Tools for Analyzing Market Outcomes (2007)Testing for Adverse Selection in Insurance Markets (2009)Crime and Punishment: An Economic Approach (1968)Law and Finance (1998)(International) R&D collaboration and SMEs: The effectiveness of targeted public R&D support schemes (2014)Artificial intelligence and productivity: global evidence from AI patent and bibliometric data (2023)Industry Structure, Market Rivalry, and Public Policy (1973)Specification Tests in Econometrics (1978)The price of innovation: new estimates of drug development costs (2003)Generic competition and market exclusivity periods in pharmaceuticals (2007)Consumer learning and heterogeneity: Dynamics of demand for prescription drugs after patent expiration (2010)Strategic Entry Deterrence and the Behavior of Pharmaceutical Incumbents Prior to Patent Expiration (2011)A Theory of Fairness, Competition, and Cooperation (1999)Risk Aversion and Incentive Effects (2002)z-Tree: Zurich toolbox for ready-made economic experiments (2007)Children discard a resource to avoid inequity. (2011)Humans display a ‘cooperative phenotype’ that is domain general and temporally stable (2014)THE RISE OF THE EAST AND THE FAR EAST: GERMAN LABOR MARKETS AND TRADE INTEGRATION (2014)
this work references cited by second hop· second hop is a sample of the most-cited connections

References

  • 2001Econometric Analysis of Cross Section and Panel Data27,575 cited
  • 1987Health insurance and the demand for medical care: evidence from a randomized experiment.2,043 cited
  • 2003Testing for Serial Correlation in Linear Panel-data Models1,573 cited
  • 2010A within-subject analysis of other-regarding preferences638 cited
  • 1992Brand Loyalty, Entry, and Price Competition in Pharmaceuticals after the 1984 Drug Act574 cited
  • 2005Uncertainty and Learning in Pharmaceutical Demand433 cited
  • 2010Patient Cost-Sharing and Hospitalization Offsets in the Elderly408 cited
  • 1997Generic Entry and the Pricing of Pharmaceuticals388 cited
  • 2012Competition Policy and Productivity Growth: An Empirical Assessment320 cited
  • 2005Generic Drug Industry Dynamics312 cited
  • 1998The Importance of the Physician in the Generic versus Trade-Name Prescription Decision300 cited
  • 2007Pharmaceutical Price Controls and Entry Strategies298 cited
  • 2004Parallel imports and the pricing of pharmaceutical products: evidence from the European Union205 cited
  • 2000Review of the literature on reference pricing203 cited
  • 2012The impact of the termination rule on cooperation in a prisoner’s dilemma experiment

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

192 cited
  • 2011How effective is European merger control?180 cited
  • Cited by

    • 2013Why are educated and risk-loving persons more mobile across regions?159 cited
    • 2013Excess Capacity and Pricing in Bertrand-Edgeworth Markets: Experimental Evidence97 cited
    • 2014Downstream mode of competition with upstream market power88 cited
    • 2012An equilibrium analysis of efficiency gains from mergers87 cited
    • 2015Policy-Induced Environmental Technology and Inventive Efforts: Is There a Crowding Out?84 cited
    • 2011Demand Estimation with Selection Bias: A Dynamic Game Approach with an Application to the US Railroad Industry83 cited
    • 2013Independent Service Operators in ATM Markets81 cited
    • 2013Input Price Discrimination (Bans), Entry and Welfare81 cited
    • 2013Effects of different cartel policies: evidence from the German power-cable industry80 cited
    • 2014Do Leniency Policies facilitate Collusion? Experimental Evidence80 cited
    • 2014Do buyer groups facilitate collusion?76 cited
    • 2014Endogenous cartel formation: Experimental evidence75 cited
    • 2013Rebels without a Clue? Experimental Evidence on Partial Cartels74 cited
    • 2014Mergers, Managerial Incentives, and Efficiencies73 cited
    • 2015Optimal Damages Multipliers in Oligopolistic Markets69 cited
    • 2016Consumer flexibility, data quality and location choice69 cited